NCT02934334 (CBN-Well) is a clinical trial of Observational in Major Depressive Disorder, sponsored by Sidney Kennedy.

Who is sponsoring NCT02934334?

NCT02934334 is sponsored by Sidney Kennedy.

What drugs are being tested in NCT02934334?

Interventions in NCT02934334: Observational.

What condition does NCT02934334 study?

NCT02934334 studies Major Depressive Disorder.

Is NCT02934334 still recruiting?

NCT02934334 is currently completed. Last updated 4 November 2020.

Last reviewed 2020-11-04 · How we verify

NCT02934334: CBN-Well

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Wellness Monitoring for Major Depressive Disorder

Completed Last updated 4 November 2020

What this trial tests

trial testing Observational in Major Depressive Disorder in 100 participants. Completed in 25 February 2019.

Timeline

31 May 2016

Primary endpoint
14 January 2019

25 February 2019

Quick facts

Lead sponsor	Sidney Kennedy
Status	Completed
Study type	OBSERVATIONAL
Enrollment	100
Start date	31 May 2016
Primary completion	14 January 2019
Estimated completion	25 February 2019
Sites	5 locations across Canada

Drugs / interventions tested

Observational — full drug profile →

Conditions studied

Major Depressive Disorder — all drugs for Major Depressive Disorder →

Sponsor

Sidney Kennedy

Who can join

Adults 18 to 65, any sex, with Major Depressive Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Wellness Monitoring for Major Depressive Disorder (MDD) study is a prospective, longitudinal, observational study aimed at identifying biomarkers of relapse in MDD. Results may help refine clinical approach to relapse management, and may ultimately help MDD patients sustain wellness while on antidepressant medication.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Personalized relapse prediction in patients with major depressive disorder using digital biomarkers.
Vairavan S, Rashidisabet H, Li QS, Ness S, et al · · 2023 · cited 12× · PMID 37903878 · DOI 10.1038/s41598-023-44592-8
Predicting Relapse of Depressive Episodes During Maintenance Treatment: The Canadian Biomarker Integration Network in Depression (CAN-BIND) Wellness Monitoring in Major Depressive Disorder Study: Prédire la rechute d'épisodes dépressifs pendant le traitement d'entretien : Une étu
Lam RW, Rnic K, Nunez JJ, Ho K, et al · · 2025 · cited 3× · PMID 40302412 · DOI 10.1177/07067437251337603

Verify or expand the search:

Other trials of Observational

Trials testing the same drug.

NCT07356700 — Deciphering the Factors of Longevity Through a Multi-Omics Study in Long-Lived Individuals in Hong Kong · not yet recruiting
NCT07381751 — Artificial Intelligence-assisted MDS-UPDRS Assessment for Parkinson's Disease · not yet recruiting
NCT07347574 — NeuroCare Community Project: A Community Based Prospective Observational Study for Early Alzheimer's Detection in HK · not yet recruiting
NCT07338968 — A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma · not yet recruiting
NCT06792994 — A Prospective Observational Trial to Assess Treatment Sequences and Factors That Impact Overall Sur-vival in Patients Wi · not yet recruiting

Other recruiting trials for Major Depressive Disorder

Currently open trials in the same condition.

NCT07219394 — Peer-Delivered Behavioral Activation in a CCBHC · NA · recruiting
NCT06705478 — Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disor · Phase 2 · recruiting
NCT06749392 — An Individual-specific Synchrony Signature · NA · recruiting
NCT07316803 — Group Intervention for Romantic Relationships in Young Adults With Severe Mental Illness · NA · recruiting
NCT07242105 — Optimizing Brain Excitability in Depression · NA · recruiting

Other Sidney Kennedy trials

Trials by the same sponsor.

NCT02998762 — Long-Term Follow Up Study · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02934334 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sidney Kennedy
Last refreshed: 4 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02934334.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing